What's new in DyslipidemiaLast update of the site: Tuesday March 02, 2021

Saba Soltani et al. | Phytotherapy Research 2021; AOP: 10.1002/ptr.6991...
Hypercholesterolemia is a major cardiovascular disease (CVD) risk factor (Lopez, Mathers, Ezzati, Jamison,...
Andrey V. Susekov   et al. | Cardiovascular Drugs and Therapy 2021;...
Elevated plasma low-density lipoprotein cholesterol (LDL-C) is a major modifiable risk factor for atherosclerotic...
Cicero, Arrigo F.G. et al. | Journal of the American College of Cardiology...
The extracts of red yeast rice (RYR) are currently the most effective cholesterol-lowering nutraceuticals....
Anderson, Josephine L.C. et al. | Journal of clinical lipidology 2021;...
Transplant vasculopathy (TV) is a major contributing factor to chronic graft failure in renal transplant...
Ciardullo, Stefano et al. | Nutrition, Metabolism and Cardiovascular...
Seasonal variations in several risk factors for cardiovascular events (CVD) were described. Here, we...
Bolek, Tomas et al. | Blood Coagulation & Fibrinolysis 2021;...
Long-term direct oral anticoagulants (DOACs), including direct thrombin inhibitor dabigatran, should...
Capucine Bertrand et al. | Diabetologia 2021; 64(3): 668-80
Lower-limb peripheral artery disease (PAD) is an emerging public health burden with an endemic progression...
Zhang, Ruiying et al. | The American Journal of Cardiology 2021;...
Patients with homozygous familial hypercholesterolemia (HoFH) have a high risk for premature death. Supravalvular...
Lorenzo Cristina et al. | Nature 2021; 589(7841): 287-92
Atherosclerosis is a chronic inflammatory disease that leads to the formation of atheroma plaques in...
Sánchez, et al. | Journal of clinical lipidology 2021;...
Familial hypercholesterolemia (FH) is an inherited disorder mainly caused by mutations in the LDL receptor...
Giovanni Caocci   et al. | Annals of Hematology 2021; aop: 10.1007/s00277-020-04392-w...
Nilotinib is a second-generation tyrosine kinase inhibitor (TKI) effective in the management of patients...
Tada, Hayato et al. | Journal of clinical lipidology 2021;...
Familial hypercholesterolemia (FH) is an autosomal dominant disorder mainly caused by mutations in the...
Gabriela Spencer‐Bonilla MD et al. | Journal of the American Geriatrics Society...
The aging population is rapidly growing, with over 20 million older adults in the United States over...
Mauri, Marta et al. | Clinica e investigacion en arteriosclerosis...
During pregnancy there is a physiological increase in total cholesterol (TC) and triglycerides (TG) plasma...
Ruiz-García, Antonio et al. | Clinica e investigacion en arteriosclerosis...
Aim To determine the crude and sex- and age-adjusted prevalence rates of atherogenic...
 Read more
More scientific & medical news in your area of expertise

Bibliographical searchFocus and target to your research of scientific data

Research by journal
631 articles currently available
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9

Top articlesThe 5 most read articles

Bolek, Tomas et al. | Blood Coagulation & Fibrinolysis 2021;...
Long-term direct oral anticoagulants (DOACs), including direct thrombin inhibitor dabigatran, should be preferred to prevent stroke and systemic embolism in patients with atrial fibrillation [1]. In addition,...
Mauri, Marta et al. | Clinica e investigacion en arteriosclerosis...
During pregnancy there is a physiological increase in total cholesterol (TC) and triglycerides (TG) plasma concentrations, due to increased insulin resistance, oestrogens, progesterone, and placental lactogen,...
Gabriela Spencer‐Bonilla MD et al. | Journal of the American Geriatrics Society...
The aging population is rapidly growing, with over 20 million older adults in the United States over 75 years old. Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death in...
Ruiz-García, Antonio et al. | Clinica e investigacion en arteriosclerosis...
Aim To determine the crude and sex- and age-adjusted prevalence rates of atherogenic dyslipidemia (AD) and low HDL-cholesterol levels (low-HDLc), and to assess their associations with...
Giovanni Caocci   et al. | Annals of Hematology 2021; aop: 10.1007/s00277-020-04392-w...
Nilotinib is a second-generation tyrosine kinase inhibitor (TKI) effective in the management of patients with chronic myeloid leukemia (CML) [1]. Despite an overall favorable safety profile, variable rates...